AVITA Medical sets annual say-on-pay votes
AVITA Medical, Inc. disclosed its decision on how often to seek stockholder advisory approval of executive compensation following its June 3, 2026 annual meeting.
Rhea-AI Filing Summary
AVITA Medical, Inc. disclosed its decision on how often to seek stockholder advisory approval of executive compensation following its June 3, 2026 annual meeting. Stockholders supported holding say-on-pay votes every year, with 9,545,151 votes for 1 year, 924,743 for 2 years, 650,252 for 3 years, 581,759 abstentions, and 3,890,542 broker non-votes.
Consistent with this outcome and the board’s recommendation, the board determined that AVITA Medical will hold future advisory votes on named executive officer compensation every year until the next required frequency vote, which will occur no later than the company’s 2032 annual meeting of stockholders.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for 1-year frequency: 9,545,151
Votes for 2-year frequency: 924,743
Votes for 3-year frequency: 650,252
+3 more
6 metrics
Votes for 1-year frequency
9,545,151
Advisory vote on executive compensation frequency at 2026 annual meeting
Votes for 2-year frequency
924,743
Advisory vote on executive compensation frequency at 2026 annual meeting
Votes for 3-year frequency
650,252
Advisory vote on executive compensation frequency at 2026 annual meeting
Abstentions
581,759
Advisory vote on executive compensation frequency at 2026 annual meeting
Broker Non-Votes
3,890,542
Advisory vote on executive compensation frequency at 2026 annual meeting
Next required frequency vote year
2032
Next required advisory vote on frequency of say-on-pay
Key Terms
non-binding advisory vote, Broker Non-Votes, emerging growth company
3 terms
non-binding advisory vote regulatory
"Stockholders voted in favor of the non-binding advisory vote to set the frequency"
A non-binding advisory vote is a shareholder vote that expresses investors’ opinion on a proposal (such as executive pay, corporate policy, or governance practices) but does not legally force the company to act. Think of it like a customer survey: it signals whether owners approve or disapprove and can pressure boards and managers to change course, so investors watch the result as an indicator of governance risk and potential future shifts in company strategy or leadership.
Broker Non-Votes regulatory
"Abstentions | Broker Non-Votes | 581,759 | 3,890,542"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
emerging growth company regulatory
"Emerging growth company Explanatory Note"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
What decision did AVITA Medical (RCEL) make about say-on-pay vote frequency?
AVITA Medical chose to hold annual advisory votes on executive compensation. This follows a stockholder vote supporting a 1-year frequency and will apply until the next required frequency vote, due no later than the 2032 annual meeting.
How did AVITA Medical (RCEL) stockholders vote on a 1-year say-on-pay frequency?
Stockholders cast 9,545,151 votes in favor of holding say-on-pay votes every year. This was the highest-supported option and aligned with the board’s recommendation on executive compensation vote frequency.
What were the vote totals for 2- and 3-year say-on-pay options at AVITA Medical (RCEL)?
The 2-year option received 924,743 votes, and the 3-year option received 650,252 votes. These totals were lower than the support for annual votes, which guided the board’s decision to adopt a 1-year frequency.
How many abstentions and broker non-votes occurred in AVITA Medical’s (RCEL) frequency vote?
There were 581,759 abstentions and 3,890,542 broker non-votes on the frequency of say-on-pay votes. These shares did not support a specific frequency option but are reported as part of the overall voting results.
When will AVITA Medical (RCEL) next hold a vote on say-on-pay frequency?
The next required advisory vote on the frequency of say-on-pay votes will occur no later than AVITA Medical’s 2032 annual meeting. Until then, the company plans to hold advisory compensation votes every year.
AI-generated analysis. How Rhea-AI works. Not financial advice.
